Drug
Inosine Pranobex clinical trials
Also written Isoprinosine.
How studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 3
Newport Pharmaceuticals International (6) · Cairo University (1) · Ain Shams University (1) · Universidad San Francisco de Quito (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Inosine Pranobex is read from its arms, and is right about nine times in ten.
Testing it · 9
- Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic TrialStatus unknownPhase 3Cairo UniversityNCT04383717Written as Levamisole and isoprinosine
- Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19Status unknownPhase 3Ain Shams UniversityNCT04360122Written as Isoprinosine
- Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mLStatus unknownPhase 4Universidad San Francisco de QuitoNCT03883334Written as Metisoprinol
- A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Patients With AIDS Related Complex (ARC)CompletedNot applicableNewport Pharmaceuticals InternationalNCT00002060Written as Inosine pranobex
- The Safety and Effectiveness of Isoprinosine in Patients With Weakened Immune Systems and Lymph Node DiseaseCompletedNot applicableNewport Pharmaceuticals InternationalNCT00002296Written as Inosine pranobex
- A Study of Isoprinosine in Patients With Severe AIDSCompletedNot applicableNewport Pharmaceuticals InternationalNCT00002295Written as Inosine pranobex
- A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed VolunteersCompletedNot applicableNewport Pharmaceuticals InternationalNCT00002059Written as Inosine pranobex
- A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized LymphadenopathyCompletedNot applicableNewport Pharmaceuticals InternationalNCT00002061Written as Inosine pranobex
- A Study of Isoprinosine in Patients With Lymph Node DiseaseCompletedNot applicableNewport Pharmaceuticals InternationalNCT00002297Written as Inosine pranobex
Codes
What other systems call Inosine Pranobex · ClinicalTrials.gg INT007695
- MeSH (NLM) D007542Inosine PranobexConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) W1SO0V223FINOSINE PRANOBEXConfirmed FDA, NLM, Wikidata
- RxNorm 6048Confirmed FDA, Wikidata
- Wikidata Q3130053inosine pranobexConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C601Inosine PranobexOne source FDA
- DrugBank DB13156One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007542 | Inosine Pranobex | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | W1SO0V223F | INOSINE PRANOBEX | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6048 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3130053 | inosine pranobex | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C601 | Inosine Pranobex | One source FDA |
| DrugBank | DB13156 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.